Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Warren G. Case"'
Publikováno v:
Journal of Clinical Psychopharmacology. 19:107-113
Long-term (mean, 8 years) users of benzodiazepines (BZs) were administered a small battery of cognitive tests on three occasions (before BZ taper, and 5 and 12 weeks post taper) as part of their BZ discontinuation program. Ninety-six patients had 5-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b93b1192e89313d77d940bb55ba95a
https://doi.org/10.1097/00004714-199904000-00003
https://doi.org/10.1097/00004714-199904000-00003
Publikováno v:
Psychopharmacology. 117:424-429
Since recent research has suggested that the major metabolites of progesterone are barbiturate-like modulators of GABAergic function, we undertook a pilot study of the efficacy of micronized progesterone in attenuating withdrawal and facilitating dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4936b9abb82308accae1fa84f5cff54
https://doi.org/10.1007/bf02246214
https://doi.org/10.1007/bf02246214
Autor:
Nicholas DeMartinis, Karl Rickels, Garcia España Fg, Laura A. Mandos, Warren G. Case, David J. Greenblatt, Edward Schweizer
Publikováno v:
Journal of clinical psychopharmacology. 18(2)
One hundred sixty-six patients suffering from major depressive disorders were treated for 8 weeks with nefazodone in an open study in dosage ranges from 200 to 600 mg. This report focuses primarily on the first week of therapy and on the concomitant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337536833c930164e2c32c66e1341620
https://pubmed.ncbi.nlm.nih.gov/9580369
https://pubmed.ncbi.nlm.nih.gov/9580369
Publikováno v:
The American journal of psychiatry. 148(6)
OBJECTIVE Clinical status and use of benzodiazepines and other psychotropic drugs at follow-up were assessed in patients who had been chronically dependent on benzodiazepines and had been referred for participation in a discontinuation study. METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61b92e829b0ea66c80d5ec6d1d181114
https://pubmed.ncbi.nlm.nih.gov/2035717
https://pubmed.ncbi.nlm.nih.gov/2035717
Publikováno v:
Clinical Neuropharmacology. 15:102A-103A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927a80c74e557b50100409ff0fdf20e4
https://doi.org/10.1097/00002826-199201001-00056
https://doi.org/10.1097/00002826-199201001-00056
Autor:
Nathanson Je, Karl Rickels, Jorge A. Pereira-Ogan, Warren G. Case, Parish Lc, Irma Csanalosi, Mirman Mj
Publikováno v:
American Journal of Psychiatry. 131:592-595
The efficacy of chlormezanone, an infrequently prescribed minor tranquilizer, was tested in a six-week double-blind trial involving 154 anxious outpatients. The results showed that chlormezanone (800 mg./day) was significantly more effective than pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::588de45f5a07330e41b205d468e09466
https://doi.org/10.1176/ajp.131.5.592
https://doi.org/10.1176/ajp.131.5.592
Publikováno v:
Stress Medicine. 4:231-239
The mainstay of drug treatment of non-psychotic anxiety is the benzodiazepine group of drugs, but major side-effects are sedation and dose-related psychomotor, cognitive and memory impairments. However, tolerance to sedation-related side-effects usua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0878ff4a2eca0b73a877293ed0a0e94
https://doi.org/10.1002/smi.2460040408
https://doi.org/10.1002/smi.2460040408
Autor:
Milton M. Perloff, Karl Rickels, Warren G. Case, William Stepansky, Harry S. Dion, Ravi K. Sapra
Publikováno v:
Psychopharmacologia. 15:265-279
Doxepin and diazepam were evaluated for therapeutic effectiveness in a double blind study carried out with 69 primarily anxious neurotic outpatients attending either a municipal hospital clinic or a general practitioner's office. Doxepin produced mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1ba80af2aa8a6b6b23811be5e6661e
https://doi.org/10.1007/bf00401681
https://doi.org/10.1007/bf00401681
Publikováno v:
The American journal of psychiatry. 146(4)
Severity of withdrawal symptoms and clinical outcome were compared in 19 elderly and 22 younger benzodiazepine-dependent patients matched for benzodiazepine half-life, dosage, and duration of treatment. During gradual taper of benzodiazepine doses, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be89db0607d132e0c627f5b6110225b7
https://pubmed.ncbi.nlm.nih.gov/2569843
https://pubmed.ncbi.nlm.nih.gov/2569843
Autor:
Hack R. Chung, Paul E. Gordon, James Hutchison, Karl Rickels, Warren G. Case, Bernard B. Zamostien
Publikováno v:
Comprehensive Psychiatry, Vol 11, Iss 5, Pp 457-474 (1970)
Hydroxyzine, in a higher than usual daily dosage (400 mg./day), was compared to chlordiazepoxide and placebo in a double-blind study conducted with 61 clinic and 69 general practice anxious neurotic outpatients. In contrast to studies in which hydrox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664044c49070c04630a95fb95489b7a5
https://pubmed.ncbi.nlm.nih.gov/4918308
https://pubmed.ncbi.nlm.nih.gov/4918308